DK59785A - Fremgangsmaade til fremstilling af i det vaesentlige fibrinogenfrit ahf - Google Patents

Fremgangsmaade til fremstilling af i det vaesentlige fibrinogenfrit ahf Download PDF

Info

Publication number: DK59785A
Authority: DK; Denmark
Prior art keywords: ahf; fibrinogen; essential; procedure; preparation
Prior art date: 1984-02-09

Application number

DK59785A

Other languages

Danish (da)

English (en)

Other versions

DK59785D0 (da

Inventor

Joseph D Fisher

Original Assignee

Armour Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-02-09

Filing date

1985-02-08

Publication date

1985-08-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24314041&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK59785(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1985-02-08 Application filed by Armour Pharma filed Critical Armour Pharma

1985-02-08 Publication of DK59785D0 publication Critical patent/DK59785D0/da

1985-08-10 Publication of DK59785A publication Critical patent/DK59785A/da

Links

102100026735 Coagulation factor VIII Human genes 0.000 abstract 4
101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 abstract 4
102000008946 Fibrinogen Human genes 0.000 abstract 3
108010049003 Fibrinogen Proteins 0.000 abstract 3
229940012952 fibrinogen Drugs 0.000 abstract 3
239000000725 suspension Substances 0.000 abstract 2
206010053567 Coagulopathies Diseases 0.000 abstract 1
239000008280 blood Substances 0.000 abstract 1
210000004369 blood Anatomy 0.000 abstract 1
239000012503 blood component Substances 0.000 abstract 1
230000035602 clotting Effects 0.000 abstract 1
239000000306 component Substances 0.000 abstract 1
239000006228 supernatant Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/829—Blood
- Y10S530/83—Plasma; serum

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Toxicology (AREA)
Gastroenterology & Hepatology (AREA)
Hematology (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Materials For Medical Uses (AREA)
Medicines Containing Plant Substances (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
Ceramic Products (AREA)
Saccharide Compounds (AREA)

DK59785A 1984-02-09 1985-02-08 Fremgangsmaade til fremstilling af i det vaesentlige fibrinogenfrit ahf DK59785A (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US06/578,724 US4486410A (en)	1984-02-09	1984-02-09	Heat defibrinogenation of AHF preparation

Publications (2)

Publication Number	Publication Date
DK59785D0 DK59785D0 (da)	1985-02-08
DK59785A true DK59785A (da)	1985-08-10

Family

ID=24314041

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK59785A DK59785A (da)	1984-02-09	1985-02-08	Fremgangsmaade til fremstilling af i det vaesentlige fibrinogenfrit ahf

Country Status (6)

Country	Link
US (1)	US4486410A (de)
EP (1)	EP0151482B1 (de)
JP (1)	JPS60184019A (de)
AT (1)	ATE62693T1 (de)
DE (1)	DE3582504D1 (de)
DK (1)	DK59785A (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4650858A (en) *	1983-03-21	1987-03-17	Nordisk Gentofte A/S	Concentrate of the antihemophilic factor VIII and a process for producing it
JPS6171064A (ja) *	1984-09-13	1986-04-11	日本赤十字社	血液成分の分離用器具
US4543210A (en) *	1984-10-04	1985-09-24	Miles Laboratories, Inc.	Process for producing a high purity antihemophilic factor concentrate
AT391808B (de) *	1986-11-03	1990-12-10	Immuno Ag	Verfahren zur herstellung einer faktor viii (ahf)-haeltigen fraktion
AU2251288A (en) *	1987-05-15	1988-12-06	Alan I. Rubinstein	Sequential improved method for treatment of human blood- clotting factor products

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4188318A (en) *	1975-06-16	1980-02-12	Edward Shanbrom	Simplified method for preparation of high yield, high purity Factor VIII concentrate
US4027013A (en) *	1976-01-22	1977-05-31	William L. Wilson	Clottable fibrinogen free factor VIII and albumin product and process
US4170639A (en) *	1978-07-10	1979-10-09	Warner-Lambert Company	Antihemophilic factor concentrate and its production
US4305871A (en) *	1980-09-02	1981-12-15	Edward Shanbrom	Method of selectively increasing yield and purity of certain cryoprecipitate proteins by heating

1984
- 1984-02-09 US US06/578,724 patent/US4486410A/en not_active Expired - Lifetime
1985
- 1985-02-05 AT AT85101181T patent/ATE62693T1/de active
- 1985-02-05 DE DE8585101181T patent/DE3582504D1/de not_active Revoked
- 1985-02-05 EP EP85101181A patent/EP0151482B1/de not_active Expired - Lifetime
- 1985-02-08 JP JP60022127A patent/JPS60184019A/ja active Pending
- 1985-02-08 DK DK59785A patent/DK59785A/da not_active Application Discontinuation

Also Published As

Publication number	Publication date
US4486410A (en)	1984-12-04
EP0151482A2 (de)	1985-08-14
EP0151482B1 (de)	1991-04-17
JPS60184019A (ja)	1985-09-19
DE3582504D1 (de)	1991-05-23
DK59785D0 (da)	1985-02-08
EP0151482A3 (en)	1987-10-07
ATE62693T1 (de)	1991-05-15

Similar Documents

Publication	Publication Date	Title
ATE73332T1 (de)	1992-03-15	Neuartige verwendung von taurolin.
UA11061A (uk)	1996-12-25	Спосіб розділеhhя білків крові
DE3483499D1 (de)	1990-12-06	Nichtdenaturierte virusfreie biologisch aktive proteinderivate.
DE59109032D1 (de)	1998-09-03	Fusionsproteine mit immunglobulinanteilen, ihre Herstellung und Verwendung
DK0547932T3 (da)	1997-02-10	Fremgangsmåde til fremstilling af et koncentrat af aktiveret faktor VII med høj renhed
DK0652966T3 (da)	2003-02-03	Fremgangsmåde til forøgelse af ekspression af virale proteiner
DE69229272D1 (de)	1999-07-01	Topischer fibrinogenkomplex
NO963602L (no)	1996-10-17	Fremgangsmåte for å oppta et biologisk klebemiddel som er laget av konsentrerte koagulasjonsfaktorer ved utsalting
DE3382837D1 (de)	2003-03-13	Herstellung von funktionellen, menschlichen Urokinaseproteinen
ES2070116T3 (es)	1995-06-01	Peptidos que inhiben la union del factor von willebrand.
DK562189D0 (da)	1989-11-09	Fremgangsmaade til isolering af biologisk aktive forbindelser
LV10053A (lv)	1994-05-10	Kompleksa "Faktors-YIII + fon Villebranda faktors" koncentrata iegusanas metode
ES2037669T3 (es)	1993-07-01	Un procedimiento para preparar una sustancia que se une a la trombina.
DK398185A (da)	1986-03-01	Pasteuriseret, hoejrenset faktor viii-praeparat og fremgangsmaade til fremstilling deraf
DK1200561T3 (da)	2006-10-16	Rekombinant stabil celleklon, dens fremstilling og anvendelse
FI865081A0 (fi)	1986-12-12	Nya (2-imidazolin-2-yl) -fusionerade heteropyridinfoereningar, mellanprodukter anvaendbara vid deras framstaellning och deras anvaendning som herbicider.
DK59785D0 (da)	1985-02-08	Fremgangsmaade til fremstilling af i det vaesentlige fibrinogenfrit ahf
DK406184D0 (da)	1984-08-24	Fremgangsmaade til pasteurisering af humanplasma
DK0772450T3 (da)	2003-04-14	Fremgangsmåder til behandling af blødningsforstyrelser
DK495786D0 (da)	1986-10-16	Fremgangsmaade til fremstilling af halogen-magnesium-alanat og alanatets anvendelse
DK209289D0 (da)	1989-04-28	Fremgangsmaade til fremstilling af indol-3-carboxylsyreestere af trans-hexahydro-8-hydroxy-2,6-methano-2h-quinolin-3(4h)-on
NO931528D0 (no)	1993-04-27	Markerte fibrinogen-reseptor-antagonister, deres anvendelse, og fremgangsmaate for deres fremstilling
Beck et al.	1976	Importance of protease inhibition in studies on purified factor VIII (antihaemophilic factor)
Clark et al.	1989	Strategy for purification of coagulation factor concentrates
Cockburn et al.	1981	Parallel destruction of factor VIII procoagulant activity and an 85,000 dalton protein in highly purified factor VIII/vWF

Legal Events

Date	Code	Title	Description
1990-10-15	AHB	Application shelved due to non-payment